Relaxin is a 6-kDa peptide of the insulin family that is present at increased levels in the circulation during pregnancy. Its functions at that time are thought to include maintenance of myometrial quiescence, regulation of plasma volume, and release of neuropeptides, such as oxytocin and vasopressin. The protein also promotes connective tissue remodeling, which allows cervical ripening and separation of the pelvic symphysis in various mammalian species. In this report, we provide evidence for a novel target of relaxin, the human monocytic cell line, THP-1. Relaxin bound with high affinity (K d ؍ 102 pM) to a specific receptor on THP-1 cells. Receptor density was low (ϳ275 receptors/cell), but binding of relaxin triggered intracelluar signaling events. Receptor density was not modulated by pretreatment with estrogen, progesterone, or a number of other agents known to induce differentiation of THP-1 cells. Cross-linking studies showed radiolabeled relaxin bound primarily to cell surface proteins with an apparent molecular mass of >200 kDa. Other members of the insulin-like family of proteins (insulin, insulin-like growth factors I and II, and relaxin-like factor) were unable to displace the binding of relaxin to THP-1 cells, suggesting that a distinct receptor for relaxin exists on this monocyte/macrophage cell line.Relaxin is a 6-kDa polypeptide with basic tertiary structural fold nearly identical to that of insulin (1). However, analysis of chemically synthesized relaxin derivatives has shown that the receptor-binding residues of the two proteins are discrete (2) and, although information is very limited (3, 4), the intracellular signaling events triggered when relaxin binds its receptor appear to be different from those triggered by insulin receptor binding. Consequently, it is not surprising that the physiological functions of relaxin are quite distinct from those of insulin and the other members of the insulin superfamily. Discovered in the 1920s, relaxin has been classically thought of as a "hormone of pregnancy" since it is present in the circulation at increased levels during pregnancy, when its synthesis is primarily directed by the corpus luteum. It serves to promote connective tissue remodeling, which allows cervical ripening and separation of the pelvic symphysis, and also acts to maintain quiescence of the myometrium (5). In addition, relaxin binding sites identified in specific areas of the brain (6) and heart (7) point to a role for it in cardiovascular function, perhaps in setting the critical thresholds for plasma volume in pregnancy (8). Relaxin is likely to play an important role in male reproductive functions as well. The protein is synthesized in the prostate, and has been shown, in vitro, to increase the motility and egg penetrating ability of sperm (9). Relaxin probably possesses non-reproductive functions as well. The identification of sites of relaxin mRNA synthesis, as well as relaxin binding sites, in the brain and heart of both males and females suggests that in those organs, the pro...